| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07565155 | Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous… | Pancreatic Adenocarcinoma | Not Yet Recruiting |
| Phase 1 | |||
| NCT06889493 | SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated… | Neuroendocrine Carcinoma | Recruiting |